🟢 20/20 Biolabs is trading 10.54% up today after cooler inflation data supported steady Fed policy

20/20 Biolabs is trading 10.54% up at $0.51 after cooler inflation data supported broader risk-on sentiment.

• The move extends its August 12, 2026 close of $0.46.
• No new company-specific announcement was identified for August 13, 2026.
• July PPI showed no monthly growth and July CPI moderated to 3.4%, supporting expectations for steady Federal Reserve policy; the S&P 500 and Nasdaq were also higher.